This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Biogen Inc. slid 3.9% to $178.30 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.2% to 6,963.74 and Dow Jones Industrial Average falling 0.8% to 49,191.99.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 6.3% short of its 52-week high of $190.20, which the company reached on January 9th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.9% to $213.65, Pfizer Inc. fell 0.5% to $25.15, and AbbVie Inc. rose 0.32% to $220.75.
Trading volume totaled 1.6 million, compared to the 50-day average of 2.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 13, 2026 16:35 ET (21:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments